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http://dx.doi.org/10.1016/j.pedneo.2Background: Chorioamnionitis is closely related to premature birth and has negative effects on
neonatal morbidity and mortality.
Methods: In this prospective study, 43 mothers who delivered earlier than 35 gestational
weeks and their 57 infants were evaluated clinically and with laboratory findings. Placentas
and umbilical cords were investigated histopathologically for chorioamnionitis and funisi-
tis.
Results: The overall frequency of clinical and histological chorioamnionitis (HCA) was 8.3%
and 23.2%, respectively. The frequency of HCA was 47.3% and 83.3% in mothers delivered
<32 weeks and <30 weeks, respectively. Maternal demographic and clinical findings and
also leukocyte and C-reactive protein values were not indicative of HCA. Infants of
mothers with HCA had significantly lower Apgar scores together with higher SNAP-PE-II
and CRIB scores. These infants had increased mechanical ventilator and surfactant re-
quirements, higher incidences of patent ductus arteriosus, early sepsis, and bronchopul-
monary dysplasia, and higher mortality rates. The effect of HCA on neonatal morbidity
and mortality was more prominent than the effect of low birthweight and lower gesta-
tional age.
Conclusion: Chorioamnionitis not only causes premature deliveries, but is also associated
with neonatal complications and increased mortality. Clinical findings and infectious
markers in mother or infant do not predict the diagnosis of histological chorioamnionitis.Neonatology, Department of Pediatrics, Ege University, Faculty of Medicine, 35100 Bornova/Izmir,
e.edu.tr (M. Yalaz).
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268 G. Erdemir et alTherefore, placental histopathology may have a role in predicting neonatal outcome in
premature deliveries, especially those below 30 weeks.
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rights reserved.1. Introduction
Chorioamnionitis (CA)dinfection of the uterine cavity,
fetal membranes, and placentadis seen in 2e4% of term
deliveries and in 25% of premature deliveries. Bacterial
invasion of the placenta generally results in abortus in early
pregnancy. The presence of infection could trigger prema-
ture delivery at the end of the second trimester. However,
due to the recognition and eradication of bacterial antigens
by the maternal immune system, the frequency of CA de-
creases in the final phases of pregnancy, and CA is more
frequent in premature deliveries below 30 weeks.1
Premature rupture of membranes (PROM) refers to
rupture of membranes (ROM) prior to the onset of labor but
beyond 37 weeks’ gestation. ROM prior to 37 weeks’
gestation is called preterm PROM (PPROM). PPROM is
responsible for one-third of premature deliveries.2 The
incidence of CA increases up to 48% with PPROM.3 Pro-
longed ROM is any ROM that persists for more than 24 hours
prior to the onset of labor; it increases neonatal sepsis
incidence 2e10-fold because of the facilitated transmission
of infectious agents to the uterine cavity via ascending
pathways, and this risk becomes four times higher when
ROM is accompanied by CA.4 CA has been proposed to affect
neonatal outcome adversely by increasing the risk of
bronchopulmonary dysplasia (BPD), necrotizing enteroco-
litis (NEC), intraventricular hemorrhage (IVH), patent
ductus arteriosus (PDA), neonatal sepsis, and neuro-
developmental sequelae.5,6
The reported incidence and possible effects of CA vary
widely among studies. These variations may be due to
several factors including the different prevalences of risk
factors in the studied populations, the use of different
diagnostic criteria, and variations in obstetric practices. CA
may be grouped as clinical or subclinical CA (CCA) and
histological CA (HCA) based on the presence or absence of
clinical signs and laboratory confirmation. The inflamma-
tion of the chorioamnion (HCA) and umbilical cord (funisi-
tis) are the manifestations of the maternal and fetal
immune responses in case of intra-amniotic infection.7,8
Histological and microbiological evidence of inflamma-
tion may not always accompany each other or clinical signs
in the mother. The frequency of HCA is higher than that of
CCA with positive bacterial cultures. The administration of
antibiotics and difficulty of growing fastidious organisms
may result in negative cultures even in the presence of
histological evidence of placental inflammation. For this
reason, pathological evaluation of the placenta is essential
for diagnosis.
Our study was conducted to show the effects of HCA on
neonatal outcome in preterm infants and to determine
whether it can be foreseen using clinical findings and lab-
oratory tests in mothers and newborns.2. Methods
The study was prospectively performed in the Medical
Faculty of Ege University between October 2004 and May
2005 after approval from the Local Ethics Committee.
Informed consent was obtained from every mother
recruited to the study.
2.1. Patients
Forty-three mothers who had delivered earlier than 35
weeks and their 57 newborn infants were recruited. Preg-
nant women with genital pathology (uterine anomaly or
cervical incompetence), chronic diseases (i.e., renal, car-
diac, hepatic, or endocrinological) or pregnancy problems
(i.e., eclampsia, HELLP syndrome, or rhesus/ABO in-
compatibility) that could lead to preterm delivery were
excluded from the study. Detailed maternal histories
including previous premature delivery, infertility treat-
ment, diabetes, fever during labor, vaginal discharge with
foul odor, and uterine sensitivity were taken. The socio-
economic status of the pregnant women was evaluated
using the Hollingshead score.9
2.2. Diagnosis of CA2.2.1. Clinical diagnosis of CA
Levels of the acute-phase marker C-reactive protein (CRP)
and complete blood counts during labor were determined
for all mothers. CCA was diagnosed based on the presence
of a fever of 38.3C or higher during labor as well as the
presence of at least two of the following criteria: leuko-
cytosis (>18,000/mm3), vaginal discharge with foul odor,
uterine sensitivity, and tachycardia (maternal >100/min,
fetal >180/min).
2.2.2. Histological diagnosis of CA
Placentas and umbilical cords were evaluated by the same
pathologist. HCA was defined as the infiltration of the
amnion, chorion, and parietal deciduas with maternal
neutrophils. Placentas were fixed in formalin for at least 24
hours; subsequently, a minimum of four samples were
taken from each placenta (two from the maternal and two
from the fetal side, as well as additional samples from re-
gions determined by macroscopic evaluation of the
placenta). In addition, samples were obtained from four
different parts of the umbilical cord and placental mem-
branes. These samples were treated with alcoholexylene
and paraffin and thus transformed into paraffin blocks.
Sections of 3 mm were cut using a microtome device. These
were stained with hematoxylineeosin and examined under
Chorioamnionitis and newborns 269a light microscope for histological signs of neutrophil infil-
tration and CA.
2.3. Neonatal evaluation
For infants, the following data were recorded: gestational
age, sex, birthweight, height, head circumference, mode of
delivery, intrauterine growth retardation (IUGR), CRIB
(Clinical Risk Index for Babies),10 SNAP-PE-II (Score for
Neonatal Acute PhysiologydPerinatal Extension-II),11 and
To¨llner sepsis scores,12 admission to the neonatal intensive
care unit (NICU), early and late sepsis, mechanical venti-
lator (MV) requirement, and the occurrence of BPD, IVH,
NEC, and mortality in the neonatal period. Infants with a
deteriorating general condition and a To¨llner sepsis score
over 5 were accepted as cases of suspected sepsis, and
antibiotic treatment was started.12 Definitive cases of
sepsis were those infants with positive blood cultures. The
sepsis cases in the first 7 days were defined as early sepsis,
and sepsis cases after the seventh day were accepted as
late sepsis. Infants who still needed oxygen support after
the 36th postconceptional week were diagnosed with BPD.13
Diagnosis and grading of IVH was done by the same radiol-
ogist with serial transfontanel ultrasonography examina-
tions using Toshiba Nemio 20 (Tokyo, Japan) ultrasound.14
Bell’s criteria were used for the diagnosis of NEC.15
2.4. Statistical analysis
All the data obtained were evaluated using SPSS (IBM,
Chicago, Illionis, USA) Windows 14.0 statistical software.
The relationship between pairwise ordinal variables wasTable 1 Demographic and clinical characteristics and risk facto
All mothers
(n Z 43)
Maternal age (years) 30.2  5.2
Gestational age (weeks) 30.8  2.9
Socioeconomic status
Good 27 (62.8%)
Middle 16 (37.2%)
Multiple pregnancy 16 (37.2%)
Infertility 15 (34.8%)
History of premature birth 2 (4.6%)
Pre-eclampsia 4 (9.3%)
Gestational diabetes 7 (16.2%)
Pyuria 18 (41.8%)
Bacterial vaginosis 9 (20.9%)
Antenatal steroid 28 (65%)
Tocolysis 29 (67.4%)
Antibiotics use 16 (37.2%)
PPROM 12 (27.9%)
Antibiotics use at PPROM 9 (75%)
Diagnosis of clinical chorioamnionitis 2 (4.6%)
White blood cell count (/mm3) 13,710  440
C-reactive protein (mg/dL) 2.9  1.8
Data are presented as mean  standard deviation or n (%) as appropr
*p values for healthy mothers and mothers with HCA.
HCA Z histological chorioamnionitis; PPROM Z preterm premature ranalyzed by Chi-square and Fisher’s exact tests. Differ-
ences between numeric variables in pairwise groups were
investigated by the Student t test, while one-way analysis
of variance was used to investigate the difference between
numeric variables in multiple groups. Correlation between
numeric variables was examined by Pearson correlation
score. Statistical significance was set to p < 0.05.
3. Results
3.1. Maternal characteristics
Demographic and clinical characteristics and the risk fac-
tors of the mothers are given in Table 1. Twenty-seven out
of 43 mothers involved in this study had singleton preg-
nancies, 15 mothers had twin pregnancies, and one mother
had a triplet pregnancy. Only one twin was included in the
study from the three twin pregnancies due to intrauterine
loss of the other twin mate. The mean age of healthy
mothers (30.1  4.7 years) was similar to the mean age of
the mothers who had HCA (30.1  6.9 years; p Z 0.81). A
good socioeconomic status was reported in 66.7% of the
healthy group and 50% of the HCA group (p Z 0.45). There
was no patient with a low socioeconomic status in the study
group, and the frequency of HCA was not found to be
related to socioeconomic status.
3.2. Incidence of HCA
HCA was detected in 10 women who delivered before 35
weeks (23.25%). It was detected in 47.3% of mothers whors of mothers.
Healthy mothers
(n Z 33)
Mothers with HCA
(n Z 10)
p*
30.1  4.7 30.1  6.9 0.81
32.0  2.0 27.5  2.5 <0.01
22 (66.7%) 5 (50%) 0.45
11 (33.3%) 5 (50%)
14 (42.2%) 2 (20%) 0.26
12 (36.3%) 3 (30%) 0.72
1 (3%) 1 (10%) 0.43
3 (9%) 1(10%) 1.00
7 (21%) d d
12 (36.3%) 6 (60%) 0.46
7 (21.2%) 2 (20%) 1.00
23 (69.6%) 5 (50%) 0.41
23 (69.6%) 6 (60%) 0.71
11 (33.3%) 5 (50%) 0.50
9 (27.2%) 3 (30%) 1.00
6 (66.7%) 3 (100%) 0.509
1 (3%) 1 (10%) 0.433
13,710  664 13,730  425 0.844
2.4  1.2 4.4  3.0 0.114
iate.
upture of membranes.
270 G. Erdemir et aldelivered before 32 weeks and in 83.3% of mothers who
delivered before 30 weeks (p < 0.01). The mean gestational
age was 30.8  2.9 weeks for all mothers in this study
group, but 32.0  2.0 weeks for mothers without HCA and
27.5  2.5 weeks in HCA group (p < 0.01). HCA was
detected in one of the two women who were considered to
have CCA.3.3. Perinatal variables and HCA relationship
Mothers with or without HCA were not significantly
different when compared for age, incidence of multiple
pregnancy, PPROM, history of previous premature delivery,
pre-eclampsia, gestational diabetes, pyuria, bacterial vag-
inosis (BV), administration of antenatal steroids, tocolytics,
and antibiotics, diagnosis of CCA, leukocyte count, and CRP
values (p > 0.05) (Table 1). The mean duration of PPROM
was 66.1  42.0 hours in the mothers (n Z 9) who had
PPROM without HCA, and 192.0  168.1 hours in the PPROM
with HCA group (n Z 3; p Z 0.94). PPROM lasting longer
than 72 hours was detected in 100% of mothers with HCA
and in 44.4% of mothers without HCA (p Z 0.20). Tocolysis
was administered to 67.4% of all mothers, of whom 60%
were detected to have HCA. The mean duration of tocolysis
was 15.4  18.1 days for the healthy group and 8.6  15.3
days for HCA group (p Z 0.59). The frequency of prenatalTable 2 The clinical and laboratory features of infants.
All infants
(n Z 57)
Gestational age (wk) 30.8  2.9
Mean birthweight (g) 1675.27  584.28
Hospitalization in NICU 45 (78.9%)
IUGR 4 (7%)
Multiple pregnancies 33 (57.8%)
Male sex 26 (45.6%)
Early sepsis 32 (56.1%)
Late sepsis 8 (14%)
Mechanical ventilator treatment 19 (33.3%)
Mechanical ventilation duration (days) 3.0  1.0
Surfactant therapy 18 (31.2%)
Use of oxygen 23 (40.3%)
Bronchopulmonary dysplasia 8 (14%)
Patent ductus arteriosus 7 (12.2%)
Necrotizing enterocolitis 1 (1.7%)
Intraventricular hemorrhage 7 (12.2%)
Neonatal mortality 9 (15.7%)
Apgar 1 min 6.35  1.5
Apgar 5 min 8.71  1.1
SNAP-PE II score 6.5  3.3
CRIB score 5.13  3.2
White blood cell count (/mm3) 10,110.2  2110.8
Hemoglobin (g/dL) 15.0  3.3
Platelets (/mm3) 242,000  71,080
C-reactive protein (mg/dL) 0.48  0.42
Data are presented as mean  standard deviation or n (%) as approp
*p values for infants of healthy mothers and of mothers with histolog
HCA Z histological chorioamnionitis; IUGR Z intrauterine growth retantibiotic administration was 37.2% in the entire study
group and 50% in the HCA group; antibiotic treatment was
given to 66.7% of cases with PPROM without HCA and to
100% of cases with PPROM and HCA (p Z 0.509).3.4. Neonatal characteristics
The demographic, clinical, and laboratory findings for the
infants are given in Table 2. A total of 57 babies were
included in the evaluations. All infants were delivered by
cesarean section. Forty-five (78.94%) out of 57 infants
(30.8  2.9 weeks, 1675.27  584.28 g, for all infants) were
delivered by healthy mothers, and 12 (21.06 %) were
delivered by mothers with HCA. Preterm deliveries earlier
than 30 weeks were observed in 83.3% of mothers with HCA.
Infants born to healthy mothers or to mothers with HCA
showed no significant differences in terms of duration of
hospitalization in NICU, multiple pregnancy rate, IUGR, sex,
oxygen use, late sepsis, NEC, IVH, cord blood CRP values,
hemoglobin values, and platelet counts. However, the
mean gestational age was significantly lower, and the early
sepsis rate, need for and duration of MV, surfactant use,
BPD, PDA, and neonatal mortality rates were significantly
higher in infants delivered by mothers with HCA, although
funisitis was not detected in any of the infants (Table 2).
Significantly lower 1- and 5-minute Apgar scores and higherInfants of healthy
mothers (n Z 45)
Infants of mothers
with HCA (n Z 12)
p*
32.0  2.0 27.5  2.5 <0.01
1849.07  522.73 1073.63  307.64 0.04
33 (73%) 12 (100%) 0.97
3 (6.6%) 1 (8.3%) 0.87
28 (62.2%) 5 (41.6%) 0.11
20 (44.4%) 6 (50%) 0.83
22 (48.8%) 10 (83.3%) 0.01
5 (11.1%) 3 (25%) 0.52
9 (20%) 10 (83.3%) <0.01
1.3  0.5 9.4  1.4 <0.01
9 (20%) 9 (75%) <0.01
15 (33.3%) 8 (66.6%) 0.07
2 (4.4%) 6 (50%) <0.01
2 (4.4%) 5 (41.6%) 0.03
d 1 (8.3%) 0.21
4 (8.8%) 3 (25%) 0.14
2 (4.4%) 7 (58.3%) <0.01
6.84  1.4 4.5  1.1 0.02
9.09  0.2 7.3  1.0 0.01
2.4  0,8 21.4  4.5 <0.01
3.72  0.9 10.1  5.3 <0.01
9,870.0  3667.1 11,000.9  4473.3 0.58
15.1  2.9 14.4  3.5 0.23
247,000  74,510 224,000  90,120 0.67
0.37  0.30 0,98  0.91 0.99
riate.
ical chorioamnionitis.
ardation; NICU Z neonatal intensive care unit.
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of clinical problems were observed in the preterm infants
of mothers with HCA. In fact, the frequency of early sepsis
rose to be as high as 83.3% (10/12) in infants born to
mothers with HCA, compared to 48.8% (22/45) in the
healthy mothers group (p Z 0.01).
3.5. Antenatal factors related to HCA and neonatal
morbidity
The effects of antenatal steroids, antibiotics, and PPROM
are summarized in Table 3. A full dose of antenatal steroids
was given to 50% of the HCA group and 69.6% of the healthy
group. Antenatal steroids had no effect on surfactant and
oxygen needs, IVH, PDA, early sepsis frequency, or devel-
opment of BPD.
Steroid administration was not related to the incidence of
HCA, since HCA was detected in 33% versus 17% of the
mothers with and without use of antenatal steroids,
respectively (p Z 0.41). The duration of MV (2.0  2.2 vs.
5.7 4.9 days) and oxygen treatment (3.2 3.7 vs. 6.6 6.2
days) were similar with or without antenatal steroids
(pZ 0.19 and pZ 0.25, respectively) (not shown in Table 3).
Antenatal antibiotic use had no significant effect on
respiratory distress syndrome (RDS) development, oxygen
need, development of early neonatal sepsis, or PDA, IVH,
and BPD development, while the surfactant requirement
was significantly higher in the infants whose mothers had
received antibiotics (Table 3).
Early neonatal morbidity, in terms of surfactant and
oxygen requirement, frequency of IVH, PDA, early sepsis,
and BPD, was not affected by the presence of PPROM in the
mother (Table 3).
We explored the relationship between HCA, antenatal
steroid use and RDS. RDS was diagnosed in four out of five
infants (80%) born to mothers with HCA, but without
antenatal steroid administration. Among the nine infants
delivered to healthy mothers who did not receive antenatal
steroids, only one infant (11.1%) had RDS. HCA increased
the risk of RDS in the absence of antenatal steroid use
(p Z 0.02). In total, seven infants were delivered from
mothers with HCA after antenatal steroid administration,
and all had RDS. Among the 36 infants born to healthy
mothers who received antenatal steroids, only eight infants
(22.2%) showed RDS. HCA also increased the frequency ofTable 3 The effects of antenatal steroids, antenatal antibiotic
neonatal prognosis.
AS(þ)
(N Z 43)
AS(e)
(N Z 14)
p Aa
(N
n (%) n (%) n
Early sepsis 23 (53.4) 9 (64.2) 0.52 12
Surfactant therapy 14 (32.5) 4 (28.5) 1.00 8
Oxygen requirement 18 (41.8) 5 (35.7) 0.74 7
Bronchopulmonay dysplasia 4 (9.3) 4 (28.3) 0.17 3
Patent ductus arteriosis 5 (11.6) 2 (14.2) 1.00 2
Intraventricular hemorrhage 5 (11.6) 2 (14.2) 1.00 2
Aab Z antenatal antibiotics; AS Z antenatal steroids.RDS in the presence of antenatal steroids, but this result
did not reach statistical significance (p Z 0.31).
Multiple regression analysis for the evaluation of multi-
ple risk factors for neonatal mortality and morbidity could
not be computed due to the low number of patients in the
subgroups. Therefore, we determined gestational age and
birthweight cut-off values of 28 weeks and 1000 g, and
explored the effects of HCA in these high-risk groups. In
order to evaluate the importance of low birthweight
compared with the presence of HCA, 12 infants born to
mothers with HCA were compared for prematurity compli-
cations classifying for birthweights over or below 1000 g
(ELBW). Surfactant use, MV duration, and oxygen require-
ment, as well as the incidences of PDA, IVH, NEC, and BPD,
and mortality rates, were similar in both groups, which
showed that the effects of maternal HCA are more promi-
nent than being born ELBW (Table 4). Similarly, when in-
fants born to mothers with HCA were grouped as below and
over 28 weeks of gestation, the frequencies of these
neonatal morbidities and mortality rates were similar in
these two groups (Table 5).
4. Discussion
Intrauterine infection is one of the frequent causes of
preterm birth.16 Prostaglandins that stimulate uterine
contractility are thought to be produced by the microbial
endotoxins and proinflammatory cytokines.16e18 Intrauter-
ine infection/inflammation not only causes preterm labor,
but is also associated with PROM and decreased response to
tocolytics.19,20 In addition, exposure to intrauterine
inflammation has a negative impact on the morbidity and
mortality of the prematurely born infant.
The incidence of HCA is reported as 60e80%, 40e50%,
and 5e30% in deliveries at gestations less than 28 weeks,
between 29 and 34 weeks, and greater than 34 weeks,
respectively.21 In the present study, HCA rate was also
found to be inversely related to week of delivery. This rate
was especially noteworthy in deliveries below 30 weeks, at
83.3%. With regard to deliveries below 35 weeks, mothers
without HCA gave birth at the 31st gestational week on
average, while the delivery week decreased to 27 weeks in
the HCA group (Table 1).
CCA was suspected in only two infants, of whom only one
was proven to have HCA. Therefore, clinical findings are nots and preterm premature rupture of membranes (PPROM) on
b(þ)
Z 14)
Aab(e)
(N Z 43)
p PPROM(þ)
(N Z 16)
PPROM(e)
(N Z 41)
p
(%) n (%) n (%) n (%)
(85.7) 20 (46.5) 0.09 14 (87.5) 18 (43.9) 0.07
(57.1) 10 (23.2) 0.03 8 (50) 10 (24.3) 0.11
(50) 16 (37.2) 0.36 8 (50) 15 (36.5) 0.52
(21.4) 5 (11.6) 0.24 3 (18.7) 5 (12.2) 1.00
(14.2) 5 (11.6) 0.68 2 (12.5) 5 (12.2) 1.00
(14.2) 5 (11.6) 0.68 2 (12.5) 5 (12.2) 1.00
Table 4 Assesment of extremely low birthweight (ELBW) and larger preterm infants who are born from mothers with
histological chorioamnionitis (HCA).
Infants of mothers
with HCA (n Z 12)
HCA(þ) <1000 g
(n Z 6)
HCA(þ) 1000 g
(n Z 6)
p*
Mean birthweight (g) 1073.63  307.64 821.6  141.9 1283.3  230.3 0.04
Mean gestational age (wk) 27.58  2.53 26.50  2.66 28.67  2.06 0.147
Mechanical ventilation duration (d) 9.4  1.4 13.6  9.8 6.0  4.9 0.17
Surfactant therapy 9 (75%) 5 (83.3%) 4 (66.6%) 0.48
Oxygen duration (d) 13.8  9.8 20.0  9.6 9.0  7.4 0.08
Bronchopulmonary dysplasia 6 (50%) 3 (50%) 3 (50%) 0.65
Patent ductus arteriosus 5 (41.6%) 2 (33.3%) 3 (50%) 0.75
Necrotizing enterocolitis 1 (8.3%) d 1 (16.7%) 0.36
Intraventricular hemorrhage 3 (25%) 1 (16.7%) 2 (33.3%) 0.56
Neonatal mortality 7 (58.3%) 5 (83.3%) 3 (50%) 0.52
Data are presented as mean  standard deviation or n (%) as appropriate.
*p values for birthweight <1000 g and 1000 g infants of mothers with HCA.
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count, CRP and IL-6 values, and glucose and cytokines in
the amniotic fluid are biochemical parameters suggested
for the diagnosis of CA, but their use in clinical evaluation is
quite limited. Sensitivity of maternal CRP value for intra-
uterine infection was found to be 27%, with a specificity of
80%, and maternal serum CRP level is not affected by
antenatal steroids.22,23 Yoon et al reported that maternal
CRP and leukocyte count were significantly higher in CA,
but amniotic fluid leukocyte count was more sensitive.24
The results of the present study demonstrated that intra-
partum leukocyte counts and CRP values are not indicative
of CA, showing the importance of amnion fluid culture and
histological evaluation of the placenta (Table 1).
Placental infection is mostly related to PPROM in preg-
nancy, and BV is known to cause PPROM.25 BV is observed in
15e40% of pregnancies and is related to a lack of prenatal
care being more commonly observed in pregnant women at
younger ages, who are single and of low socioeconomic
status.26,27 Since vaginal cultures were not taken regularly,
foul odorous vaginal discharge was evaluated as BV in
around 20% of both the HCA and healthy groups. Although
these numbers are close to the rates reported in theTable 5 Assesment of effects of histological chorioamnionitis (
Infants of mothers
with HCA (n Z 12)
Mean birthweight (g) 1052.5  302.3
Mean gestational age (wk) 27.58  2.53
Mechanical ventilation duration (d) 9.4  8.1
Surfactant therapy 9 (75%)
Oxygen duration (d) 13.8  9.8
Bronchopulmonary dysplasia 6 (50%)
Patent ductus arteriosus 5 (41.6%)
Necrotizing enterocolitis 1 (8.3%)
Intraventricular hemorrhage 3 (25%)
Neonatal mortality 7 (58.3%)
Data are presented as mean  standard deviation or n (%) as approp
*p values for gestational age <28 weeks and 28 weeks infants of mliterature, this diagnostic limitation might have caused the
failure to show the relation between BV and the presence
of HCA (Table 1). We also could not detect any significant
relationship between the socioeconomic status of the
mothers and HCA in our study (Table 1).
PROM is observed in 2e3.5% of term but in up to 30e40%
of preterm deliveries.2, 28 PPROM either forms an entrance
route for infectious factors to reach the sterile amniotic
cavity, or is caused by a primary subclinical infection. Both
opinions support the view that inflammatory cytokines start
labor.19 In the present study, PPROM was present in 27.9% of
pregnant woman who delivered earlier than 35 weeks, and
30% of these women had HCA. Only one (8.3%) pregnant
women with PPROM had clinical signs of CA, showing the
lack of sensitivity of the clinical findings. In the comparison
of pregnant women with and without HCA, there was no
significant difference in terms of the presence and duration
of PPROM (Table 1). This shows that, even in the absence of
clinical signs and PPROM, HCA may still be present in case
of premature labor.
Underlying CA is considered to cause labor and delivery
that cannot be stopped by the tocolytics.20 However, in our
study, the efficacy of tocolytics was similar in mothers whoHCA) below and over 28 weeks of gestation.
HCA(þ) <28 wk
(n Z 7)
HCA(þ) 28 wk
(n Z 5)
p*
881.43  157.77 1292.0  301.77 0.011
25.8  1.46 30.0  1.41 0.001
10.00  8.48 8.80  8.70 0.823
6 (85.7%) 3 (60%) 1.00
17.50  10.21 11.00  9.53 0.357
3 (75%) 3 (60%) 1.00
3 (42.8%) 2 (40%) 1.00
1 (14.2%) d d
2 (28.5%) 1 (20%) 1.00
4 (57.1%) 3 (60%) 1.00
riate.
others with HCA.
Chorioamnionitis and newborns 273delivered prematurely due to HCA or other reasons, since
the presence and mean durations of tocolysis were similar
between groups (Table 1).
Antibiotic use in the perinatal period is only suggested in
the presence of PPROM or indicators of infection to reduce
neonatal mortality and complications of prematurity in in-
fants.28 However, some studies report that PPROM is based
on the underlying subclinical infection, and that antibiotics
cannot stop the ongoing inflammatory process and reduce
neonatal sepsis risk.29 In the present study, neither the
presence nor the duration of PPROM and antibiotic treat-
ment were related to the frequency of CA, suggesting
either that resistant strains were active or that the ongoing
inflammatory process could not be stopped by antibiotics.
The benefits of antenatal antibiotics shown in some short-
term outcomes should be balanced against the lack of ev-
idence for the benefit of others, including perinatal mor-
tality and longer term outcomes.28 In our study, group
antibiotic treatment was given to all pregnant women with
PPROM upon clinical and laboratory infectious findings. We
observed that although 50% of mothers with HCA had
received antibiotics in the perinatal period, the incidence
of early sepsis, BPD, PDA, NEC, and IVH, as well as mor-
tality, was not reduced.
Antenatal steroids were previously thought to increase
the frequency of perinatal infection in mothers and infants;
however, it was later reported that steroids reduced
certain negative effects of CA such as IVH and RDS, as well
as mortality by suppression of inflammation.30 In the pre-
sent study, antenatal steroids did not alter the frequency of
HCA in pregnant women (Table 1). No protective effects of
antenatal corticosteroids were observed for any of the
neonatal morbidities in our group of infants (Table 3). HCA
increased RDS frequency significantly unrelated to ante-
natal steroid use.
CA both causes preterm birth and aggravates problems
and complications of prematurity. Intrauterine bacterial in-
fections in newborns present with early neonatal sepsis. In-
trauterine infection accelerates fetal lung maturation
similar to the stress response, but inflammatory cytokines
cause alveolarization to deteriorate, and this leads to the
development of chronic lung disease.31 Cytokines have
direct effects on the central nervous system, cause apoptosis
by increasing the activity of caspase and excitatory amino
acid synthesis, and negatively affect neurological develop-
ment by causing fetal hypotension. Inflammation increases
the sensitivity of neurons to damage by hypoxia and thus
aggravates hypoxiceischemic damage.32
Ogunyemi et al reported that pregnant women with HCA
give birth earlier (at approximately 28.4 weeks); neonatal
morbidities including BPD, PDA, IVH, and early neonatal
sepsis are more frequent; and neonatal mortality is also
higher in these infants.5 Studies performed in recent years
have reported that mortality, morbidity, early neonatal
sepsis, and frequencies of RDS, BPD, and IVH increased in
the infants of pregnant women with CA.5,6 In the present
study, early neonatal sepsis, RDS, surfactant use, BPD, and
PDA were found to be more frequent, and neonatal mor-
tality was significantly increased in the preterm infants of
mothers with HCA compared to preterm infants born to
otherwise healthy mothers. Although IVH was observed in
25% and 8.8% of the respective groups, the difference wasnot statistically significant, which could be due to the small
number in the study group (Table 2).
A significant relationship has been reported between
HCA and low Apgar scores/severity of illness in different
studies.6,33 In the present study, the mean 1- and 5-minutes
Apgar scores were also significantly lower, and the CRIB and
SNAP-PE II scores were significantly higher, in the HCA
group, showing the severity of illness and the increased
need for intensive care support (Table 2).
Leukocyte count in the cord blood has low sensitivity
(74%) and specificity for the diagnosis of early neonatal
sepsis, since it is affected by many other factors such as
difficult delivery and induction with oxytocin (56%).34 CRP
can be indicative of intrauterine infection as it crosses the
placenta and rapidly increases in inflammatory events.
However, high cord blood CRP level is related not only to
infection, but also to PROM longer than 24 hours and
maternal fever, prolonged labor, and the presence of
meconium in the amnion. Therefore, negative CRP values
are more important for ruling out infection.4,35 In the pre-
sent study, the mean leukocyte count and CRP values
seemed to be higher in the infants of mothers with HCA
than those of healthy group, but this difference was not
statistically significant (Table 2).
Morbidity and mortality rates are reported to be much
higher in ELBW infants of mothers with HCA.36 ELBW infants
in our study group had similar surfactant, MV, and oxygen
needs and mortality rates compared to larger preterms
born to mothers with HCA. Moreover, infants born to
mothers with HCA before or after 28 weeks had similar
outcomes, which suggested that the relationship between
CA and poor neonatal prognosis was not solely related to
early gestational age or extremely low birthweight, but also
to HCA (Tables 4 and 5).
As a whole, the incidence of HCA increased remarkably
with decreasing gestational age at delivery, and the de-
livery week fell to the 27th gestational week in the HCA
group in the present study. Antenatal steroid administra-
tion neither increased HCA frequency nor reduced the
neonatal complications due to HCA. Clinical characteristics
and acute-phase indicators of both mother and infant were
not predictive of HCA and early sepsis. Apgar scores at
1 and 5 minutes were significantly lower in infants born to
mothers with HCA, and the neonatal scoring systems yiel-
ded higher scores, indicating clinical severity. HCA not only
causes preterm delivery, but may also have significant
negative effects on neonatal prognosis independent of
lower gestational age and low birthweight.
In conclusion, HCA is an important cause of neonatal
mortality and morbidity, but it remains difficult to predict
by clinical or laboratory methods. Therefore, routine his-
topathological examination of the placenta, also known as
the “black box” of pregnancy, can provide valuable infor-
mation to the clinician.References
1. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB,
Eschenbach DA, et al. Risk factors for preterm premature
rupture of fetal membranes: a multicenter case-control study.
Am J Obstet Gynecol 1990;163:130e7.
274 G. Erdemir et al2. Parry S, Strauss 3rd JF. Premature rupture of the fetal mem-
branes. N Engl J Med 1998;338:663e70.
3. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB,
Eschenbach DA. The relationship of amniotic fluid cytokines and
preterm delivery, amniotic fluid infection, histologic cho-
rioamnionitis, and chorioamnion infection.Obstet Gynecol 1993;
81:941e8.
4. Edwards MS. Postnatal bacterial infections. In: Martin RJ,
Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s
neonatal perinatal medicine disease of the fetus and ınfant.
8th ed., vol. 2. Philadelphia: Mosby Elsevier; 2006. p. 791e804.
5. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The
relationship between placental histopathology findings and
perinatal outcome in preterm infants. J Matern Fetal Neonatal
Med 2003;13:102e9.
6. Dexter SC, Malee MP, Pinar H, Hogan JW, Carpenter MW,
Vohr BR. Influence of chorioamnionitis on developmental
outcome in very low birth weight infants. Obstet Gynecol 1999;
94:267e73.
7. Smulian JC, Shen-Schwarz S, Vintzileos AM, Lake MF,
Ananth CV. Clinical chorioamnionitis and histologic placental
inflammation. Obstet Gynecol 1999;94:1000e5.
8. Steel JH, O’Donoghue K, Kennea NL, Sullivan MH, Edwards AD.
Maternal origin of inflammatory leukocytes in preterm fetal
membranes, shown by fluorescence in situ hybridisation.
Placenta 2005;26:672e7.
9. Coplan J, Jawad AF. Modeling clinical outcome of children with
autistic spectrum disorders. Pediatrics 2005;116:117e22.
10. The CRIB (clinical risk index for babies) score: a tool for
assessing initial neonatal risk and comparing performance of
neonatal intensive care units. The International Neonatal
Network. Lancet 1993;342:193e8.
11. Richardson DK, Phibbs CS, Gray JE, McCormick MC, Workman-
Daniels K, Goldmann DA. Birth weight and illness severity: in-
dependent predictors of neonatal mortality. Pediatrics 1993;
91:969e75.
12. To¨llner U. Early diagnosis of septicemia in the newborn. Clin-
ical studies and sepsis score. Eur J Pediatr 1982;138:331e7.
13. Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease
following respirator therapy of hyaline-membrane disease.
Bronchopulmonary dysplasia. N Engl J Med 1967;276:
357e68.
14. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and
evolution of subependymal and intraventricular hemorrhage: a
study of infants with birth weights less than 1,500 gm.
J Pediatr 1978;92:529e34.
15. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment
based on staging criteria. Pediatr Clin North Am 1986;33:
179e201.
16. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology
and causes of preterm birth. Lancet 2008;371:75e84.
17. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection
and preterm delivery. N Engl J Med 2000;342:1500e7.
18. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The
agent of bacillary angiomatosis. An approach to the identifi-
cation of uncultured pathogens. N Engl J Med 1990;323:
1573e80.
19. Romero R, Go´mez R, Chaiworapongsa T, Conoscenti G, Kim JC,
Kim YM. The role of infection in preterm labour and delivery.
Paediatr Perinat Epidemiol 2001;15(Suppl 2):41e56.20. Torricelli M, Voltolini C, Conti N, De Bonis M, Biliotti G,
Picciolini E, et al. Inflammatory and infectious risk factors are
associated with the response to tocolysis in patients with
preterm labor. J Matern Fetal Neonatal Med 2011;24:43e6.
21. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is
associated with early survival after preterm birth. Am J Obstet
Gynecol 2004;190:147e51.
22. Saini S, Goel N, Sharma M, Arora B, Garg N. C-reactive proteins as
an indicator of sub-clinical infection in cases of premature
rupture ofmembranes. Indian J Pathol Microbiol 2003;46:515e6.
23. Kayem G, Maillard F, Schmitz T, Jarreau PH, Cabrol D, Breart G,
et al. Prediction of clinical infection in women with preterm
labour with intact membranes: a score based on ultrasono-
graphic, clinical and biological markers. Eur J Obstet Gynecol
Reprod Biol 2009;145:36e40.
24. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The
relationship among inflammatory lesions of the umbilical cord
(funisitis), umbilical cord plasma interleukin 6 concentration,
amniotic fluid infection, and neonatal sepsis. Am J Obstet
Gynecol 2000;183:1124e9.
25. Goffinet F. Primary predictors of preterm labour. BJOG 2005;
112(Suppl 1):38e47.
26. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in
the prevention of infection-associated preterm birth. Am J
Obstet Gynecol 2004;190:1493e502.
27. Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T,
Labianca A, et al. Vaginal microbial flora and outcome of preg-
nancy. Arch Gynecol Obstet 2010;281:589e600.
28. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture
of membranes. Cochrane Database Syst Rev 2010;8:CD001058.
http://dx.doi.org/10.1002/14651858.CD001058.pub2.
29. Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for
pre-term pre-labour rupture of membranes: prevention of
neonatal deaths due to complications of pre-term birth and
infection. Int J Epidemiol 2010;39(Suppl 1):i134e43.
30. Been JV, Degraeuwe PL, Kramer BW, Zimmermann LJ. Ante-
natal steroids and neonatal outcome after chorioamnionitis: a
meta-analysis. BJOG 2011;118:113e22.
31. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M,
Moore M, et al. Chorioamnionitis, mechanical ventilation, and
postnatal sepsis as modulators of chronic lung disease in pre-
term infants. J Pediatr 2002;140:171e6.
32. Ku¨ltu¨rsay N. Fetal neonatal proinflammatory cytokine response
e relation to perinatal brain and lung injury. Cocuk Sagligi ve
Hastaliklari Dergisi 2003;46:299e307. [In Turkish].
33. Botet F, Figueras J, Carbonell-Estrany X, Arca G, The Castrillo
Study Group. Effect of maternal clinical chorioamnionitis on
neonatal morbidity in very-low birthweight infants: a case-
control study. J Perinat Med 2010;38:269e73.
34. Rozycki HJ, Stahl GE, Baumgart S. Impaired sensitivity of a
single early leukocyte count in screening for neonatal sepsis.
Pediatr Infect Dis J 1987;6:440e2.
35. Mathai E, Christopher U, Mathai M, Jana AK, Rose D,
Bergstrom S. Is C-reactive protein level useful in differenti-
ating infected from uninfected neonates among those at risk of
infection? Indian Pediatr 2004;41:895e900.
36. De Felice C, Toti P, Parrini S, Del Vecchio A, Bagnoli F, Latini G,
et al. Histologic chorioamnionitis and severity of illness in very
low birth weight newborns. Pediatr Crit Care Med 2005;6:
298e302.
